Autobio Diagnostics Co., Ltd. (SHA:603658)
China · Delayed Price · Currency is CNY 36.20
+0.18 (0.50%)
At close: Dec 19, 2025
Autobio Diagnostics Market Cap
Autobio Diagnostics has a market cap or net worth of 20.69 billion as of December 19, 2025. Its market cap has decreased by -19.01% in one year.
Market Cap
20.69B
Enterprise Value
19.97B
Revenue
4.22B
Ranking
n/a
PE Ratio
18.87
Stock Price
36.20
Market Cap Chart
Since September 1, 2016, Autobio Diagnostics's market cap has increased from 8.82B to 20.69B, an increase of 134.53%. That is a compound annual growth rate of 9.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 20.69B | -17.15% |
| Dec 31, 2024 | 24.97B | -24.62% |
| Dec 29, 2023 | 33.12B | -8.65% |
| Dec 30, 2022 | 36.26B | 12.33% |
| Dec 31, 2021 | 32.28B | -50.70% |
| Dec 31, 2020 | 65.47B | 61.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 393.11B |
| WuXi AppTec | 269.05B |
| Shenzhen Mindray Bio-Medical Electronics | 237.48B |
| Sichuan Biokin Pharmaceutical | 145.15B |
| Aier Eye Hospital Group | 104.48B |
| Shanghai United Imaging Healthcare | 104.30B |
| Zhangzhou Pientzehuang Pharmaceutical., | 103.08B |
| Yunnan Baiyao Group Co.,Ltd | 99.72B |